BioHarvest Sciences Inc. (NASDAQ:BHST – Get Free Report)’s share price traded up 0.9% during trading on Monday . The stock traded as high as $4.40 and last traded at $4.31. 19,419 shares traded hands during trading, an increase of 12% from the average session volume of 17,297 shares. The stock had previously closed at $4.27.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on BHST shares. Roth Mkm started coverage on BioHarvest Sciences in a report on Thursday, February 19th. They issued a “buy” rating and a $10.00 target price for the company. Weiss Ratings restated a “sell (d-)” rating on shares of BioHarvest Sciences in a report on Monday, December 29th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $13.00.
Check Out Our Latest Stock Report on BHST
BioHarvest Sciences Stock Up 0.7%
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in BHST. Virtu Financial LLC acquired a new stake in BioHarvest Sciences in the fourth quarter valued at approximately $60,000. Geode Capital Management LLC acquired a new position in shares of BioHarvest Sciences during the fourth quarter worth approximately $61,000. HRT Financial LP bought a new position in shares of BioHarvest Sciences in the 4th quarter worth $75,000. Marshall Wace LLP acquired a new stake in BioHarvest Sciences in the 4th quarter valued at $110,000. Finally, Quadrature Capital Ltd acquired a new stake in BioHarvest Sciences in the 4th quarter valued at $140,000.
BioHarvest Sciences Company Profile
BioHarvest Sciences Inc is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.
The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets.
Featured Articles
Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
